HDFC Charity Fund for Cancer Cure (Feb 2030)

What if your investment could do something meaningful beyond your own financial goals? What if a part of the income generated from your investment could help an underprivileged cancer patient receive treatment?

That is the thoughtful idea behind HDFC Charity Fund for Cancer Cure (Feb 2030). Launched by HDFC Mutual Fund in association with the Indian Cancer Society (ICS), this scheme brings together a fixed-tenure debt investment and an opportunity to contribute towards cancer treatment.

Let’s understand its features, dates and working in detail.

1. What is HDFC Charity Fund for Cancer Cure?

It is a close-ended income scheme with a tenure of 1,169 days. The scheme primarily invests in debt instruments, money-market instruments and Government Securities that mature on or before the scheme’s maturity date. It may also hold units of debt mutual fund schemes.

The scheme does not invest in equities.

Its investment objective is to generate income over the tenure. However, returns are not guaranteed.

2. Important NFO and scheme dates

Here are the key dates investors should know:

  • NFO opening date: 16 November 2026
  • NFO closing date: 30 November 2026
  • NFO price: ₹10 per unit
  • Scheme tenure: 1,169 days from the date of allotment
  • Scheduled maturity date: 11 February 2030
  • Minimum investment: ₹50,000
  • Additional investment after the minimum: In multiples of ₹1,000 during the NFO
  • Entry load: Nil
  • Exit load: Not applicable

The maturity date is 11 February 2030. If that date falls on a non-business day, the immediately succeeding business day will be treated as the maturity date.

3. Who will manage the fund?

The Scheme Information Document identifies the following fund managers:

  • Mr. Anil Bamboli: Fund Manager for the scheme’s investments. He is Head – Fixed Income at HDFC AMC and has over 32 years of collective experience in fund management, research and fixed-income dealing.
  • Mr. Gopal Agrawal: Fund Manager for overseas investments. He is a Senior Fund Manager – Equities and also manages overseas investments at HDFC AMC.

4. How does the charity contribution work?

This is the most distinctive feature of the scheme.

At the time of investment, investors can select one of two donation options:

  • 50% IDCW Donation Option – 50% of the gross IDCW is donated to the Indian Cancer Society.
  • 75% IDCW Donation Option – 75% of the gross IDCW is donated to the Indian Cancer Society.

The 50% option is the default.

The donation is facilitated through a one-time mandate in favour of the Indian Cancer Society. Importantly, your invested capital is not donated. Only the selected portion of the IDCW is contributed. Your units remain invested, and the maturity proceeds are payable to you.

HDFC AMC will also contribute an amount equivalent to eligible investor donations, subject to a maximum of ₹16 crore per financial year.

5. Where will the money be invested?

The scheme focuses on debt and money-market instruments, Government Securities and permitted fixed-income investments. The underlying securities are intended to mature on or before the scheme’s maturity date.

Its benchmark is the NIFTY Medium Duration Debt Index A-III.

The scheme carries a Moderate risk label. Its Potential Risk Class is A-III, indicating relatively high interest-rate risk and relatively low credit risk.

6. Is it really close-ended?

Yes. This is an important point.

Investors can subscribe only during the NFO period. After the NFO, the scheme will not reopen for fresh subscriptions.

The units are proposed to be listed on NSE and/or BSE. Investors cannot directly redeem their units with the mutual fund before maturity. Any sale on the exchange would depend on the availability of buyers and prevailing market prices.

At maturity, redemption proceeds will be paid at the applicable NAV, generally within three working days of the maturity date, subject to applicable provisions.

7. Who should consider this scheme?

It may be worth considering for investors who:

  • Can remain invested for the complete tenure.
  • Understand the risks associated with debt investments.
  • Want a fixed-tenure investment with a meaningful charitable contribution.
  • Wish to support cancer treatment without donating their invested capital.

The SID also mentions potential tax deduction eligibility on donations under Section 133 of the Income Tax Act, 2025, subject to applicable conditions and the investor’s tax circumstances. Investors should consult their tax adviser before relying on any tax benefit.

My perspective as a mutual fund distributor

I believe the most meaningful part of this initiative is its purpose. It creates an opportunity to participate in a debt investment while supporting people who may need financial assistance for cancer treatment.

However, a noble cause should not be the only reason to invest. Investors must evaluate the tenure, liquidity restrictions, interest-rate risk, credit risk and their own financial requirements.

An investment should fit your financial plan, and a contribution should come from an informed choice.

Also Read: The 7-5-3-1 Rule: The SIP Formula I Wish Every Investor Understood

Disclaimer: Mutual Fund investments are subject to market risks. Please read all scheme-related documents carefully before investing. This article is for investor education and is not an investment recommendation. The scheme does not guarantee returns or the declaration of IDCW.

Did you find this interesting

Subscribe to get latest updates

Leave a Reply

Your email address will not be published. Required fields are marked *